Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Precision intervention for prostate cancer: Re-evaluating who is at risk

Cancer Letters(2022)10.1016/j.canlet.2022.215709Source: DataRank Database

Precision intervention for prostate cancer: Re-evaluating who is at risk is a research paper published in Cancer Letters (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

refsnp nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 2.45)OA: greenTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Cory Abate‐Shen ORCID,Alexandros Papachristodoulou ORCID

Live enrichment

PubMed:35490919 PMC:PMC9136709 OpenAlex:https://openalex.org/W4225257915

National Institutes of Health

Grant: CA183929

Prostate Cancer Foundation

Grant: 21YOUN32

Center for Scientific Review

Grant: CA173481

Center for Scientific Review

Grant: CA233176

Center for Scientific Review

Grant: CA265768

NCI NIH HHS

Grant: P01 CA265768

NCI NIH HHS

Grant: R01 CA173481

NCI NIH HHS

Grant: R01 CA233176

NCI NIH HHS

Grant: R01 CA183929

Center for Strategic Scientific Initiatives

FWCI

2.45

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9136709

publisherhttps://api.elsevier.com/content/article/PII:S0304383522001938?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304383522001938?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.canlet.2022.215709

Fields of Study

Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchGenetic factors in colorectal cancer

MeSH Terms

Clinical Decision-MakingAgedHumansMaleProstatic NeoplasmsProstate-Specific AntigenGenetic Predisposition to Disease

Keywords

Prostate cancerMedicineDiseaseIntervention (counseling)CancerPopulationRisk assessmentOncologyProstateRisk stratificationIntensive care medicineGynecologyInternal medicineEnvironmental healthMitochondrial DNArisk factorsGenetic VariantsActive SurveillancePrecision Prevention And Treatment

Sustainable Development Goals

SDG 0: Good health and well-being

Precision intervention for prostate cancer: Re-evaluating who is at risk

FAIR Checklist

Authors (2)

Funding (10 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)